Accurate Evaluation Precise Architecture
of Human Biology
of Human Biology
What We do CurioChip Enabled Disease Models
Recreating All Aspects of Human Disease
Human Cells
CurioChips
Patient-derived Data
Omics & Literature
Databases
Qureator Human Disease Models
Testing Modalities:
- Small molecule
- Biologics/Antibodies
- Cell & Genen Therapies
- CRISPRi
- etc…
New Target Identification
Discovery of Synergistic Combinations
Efficacy & Dosage Prediction
Our Technology Strong Integration Between
High Throughput MPS and AI
High Throughput MPS and AI
Patient samples & primary cells
Tumor 
Organoid
Stromal
Endothelial
Immune
Epithelial
Genetics
and Omics
and Omics
Image Feature
Extraction
Extraction
Biochemical
Analysis
Analysis
Target Validation Combination Targets
Dose Responses
Best Drug Candidates
Best Drug Candidates
Biomarkers
Patient Stratification
Patient Stratification
News Latest Updates
Qureator’s Collaboration Highlighted in Korean Economic Daily
Qureator’s pioneering work in advanced 3D disease modeling was recently spotlighted by the Korean Economic Daily in coverage of our collaboration with SillaJen Inc.
Qureator Unveils AI-Driven Lab-in-the-Loop Platform for Scalable, Personalized Drug Discovery at BIO 2025
Qureator is proud to unveil the future of drug discovery at BIO 2025.
Qureator Showcases Groundbreaking 3D Blood-Retinal Barrier Model at ARVO 2025
Qureator is proud to announce its participation at ARVO 2025, unveiling its pioneering iPSC-derived 3D outer Blood-Retinal Barrier (oBRB) model. Using Curiochips™ technology, the model faithfully replicates key features of both…